FDA orphan drug designation: treatment of short stature in Turner syndrome
All entries for: BioMarin Pharmaceutical Inc.
July 11, 2025
BioMarin Pharmaceutical Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of short stature in Turner syndrome
